These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 33571286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
    Recine N, Palma E, Domenici L, Giorgini M, Imperiale L, Sassu C, Musella A, Marchetti C, Muzii L, Benedetti Panici P.
    Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
    [Abstract] [Full Text] [Related]

  • 5. Rationale and Safety Assessment of a Novel Intravaginal Drug-Delivery System with Sustained DL-Lactic Acid Release, Intended for Long-Term Protection of the Vaginal Microbiome.
    Verstraelen H, Vervaet C, Remon JP.
    PLoS One; 2016 Jan; 11(4):e0153441. PubMed ID: 27093291
    [Abstract] [Full Text] [Related]

  • 6. Acceptability of and treatment preferences for recurrent bacterial vaginosis-Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial.
    Anstey Watkins J, Ross JDC, Thandi S, Brittain C, Kai J, Griffiths F.
    PLoS One; 2019 Jan; 14(11):e0224964. PubMed ID: 31730666
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vaginal microbiome.
    Buchta V.
    Ceska Gynekol; 2018 Jan; 83(5):371-379. PubMed ID: 30848142
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Lactobacillus crispatus isolates from Lactobacillus-dominated vaginal microbiomes with isolates from microbiomes containing bacterial vaginosis-associated bacteria.
    Abdelmaksoud AA, Koparde VN, Sheth NU, Serrano MG, Glascock AL, Fettweis JM, Strauss JF, Buck GA, Jefferson KK.
    Microbiology (Reading); 2016 Mar; 162(3):466-475. PubMed ID: 26747455
    [Abstract] [Full Text] [Related]

  • 10. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C, Deng ZL, Vital M, Masur C, Abels C, Pieper DH, Rohde M, Mendling W, Wagner-Döbler I.
    Microbiome; 2017 Sep 13; 5(1):119. PubMed ID: 28903767
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of a lactic acid plus lactoserum intimate liquid soap for external hygiene in the prevention of bacterial vaginosis recurrence after metronidazole oral treatment.
    Bahamondes MV, Portugal PM, Brolazo EM, Simões JA, Bahamondes L.
    Rev Assoc Med Bras (1992); 2011 Sep 13; 57(4):415-20. PubMed ID: 21876923
    [Abstract] [Full Text] [Related]

  • 14. The role of lactic acid production by probiotic Lactobacillus species in vaginal health.
    Tachedjian G, Aldunate M, Bradshaw CS, Cone RA.
    Res Microbiol; 2017 Sep 13; 168(9-10):782-792. PubMed ID: 28435139
    [Abstract] [Full Text] [Related]

  • 15. Metronidazole with Lactacyd vaginal gel in bacterial vaginosis.
    Decena DC, Co JT, Manalastas RM, Palaypayon EP, Padolina CS, Sison JM, Dancel LA, Lelis MA.
    J Obstet Gynaecol Res; 2006 Apr 13; 32(2):243-51. PubMed ID: 16594932
    [Abstract] [Full Text] [Related]

  • 16. Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis.
    Armstrong-Buisseret L, Brittain C, David M, Dean G, Griffiths F, Hepburn T, Jackson L, Kai J, Montgomery A, Roberts T, Thandi S, Ross JDC.
    Trials; 2019 Nov 27; 20(1):648. PubMed ID: 31775859
    [Abstract] [Full Text] [Related]

  • 17. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU, Singh R, Mitchev N, Mlisana K, Jaspan HB, Barnabas SL, Passmore JS.
    BMC Infect Dis; 2020 Jul 10; 20(1):491. PubMed ID: 32650729
    [Abstract] [Full Text] [Related]

  • 18. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis.
    Deng ZL, Gottschick C, Bhuju S, Masur C, Abels C, Wagner-Döbler I.
    mSphere; 2018 Jun 27; 3(3):. PubMed ID: 29875146
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.